Literature DB >> 11093133

Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain-immunized mice and their offspring.

L Giordanengo1, C Maldonado, H W Rivarola, D Iosa, N Girones, M Fresno, S Gea.   

Abstract

Human and murine infection with Trypanosoma cruzi parasite is usually accompanied by strong humoral and cellular immune response to cruzipain, a parasite immunodominant antigen. In the present study we report that the immunization of mice with cruzipain devoid of enzymatic activity, was able to induce antibodies which bind to a 223-kDa antigen from a mouse heart extract. We identified this protein as the mouse cardiac myosin heavy chain by sequencing analysis. The study of IgG isotype profile revealed the occurrence of all IgG isotypes against cruzipain and myosin. IgG1 showed the strongest reactivity against cruzipain, whereas IgG2a was the main isotype against myosin. Anti-cruzipain antibodies purified by immunoabsorption recognized the cardiac myosin heavy chain, suggesting cross-reactive epitopes between cruzipain and myosin. Autoimmune response in mice immunized with cruzipain was associated to heart conduction disturbances. In addition, ultrastructural findings revealed severe alterations of cardiomyocytes and IgG deposit on heart tissue of immunized mice. We investigated whether antibodies induced by cruzipain transferred from immunized mothers to their offsprings could alter the heart function in the pups. All IgG isotypes against cruzipain derived from transplacental crossing were detected in pups' sera. Electrocardiographic studies performed in the offsprings born to immunized mothers revealed conduction abnormalities. These results provide strong evidence for a pathogenic role of autoimmune response induced by a purified T. cruzi antigen in the development of experimental Chagas' disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093133     DOI: 10.1002/1521-4141(200011)30:11<3181::AID-IMMU3181>3.0.CO;2-A

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Anti-galectin-1 autoantibodies in human Trypanosoma cruzi infection: differential expression of this beta-galactoside-binding protein in cardiac Chagas' disease.

Authors:  L Giordanengo; S Gea; G Barbieri; G A Rabinovich
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

2.  Trypanosoma cruzi antigen immunization induces a higher B cell survival in BALB/c mice, a susceptible strain, compared to C57BL/6 B lymphocytes, a resistant strain to cardiac autoimmunity.

Authors:  Andrea Pellegrini; Eugenio Antonio Carrera-Silva; Alfredo Arocena; Roxana Carolina Cano; Maria Pilar Aoki; Susana Gea
Journal:  Med Microbiol Immunol       Date:  2011-03-24       Impact factor: 3.402

Review 3.  Chagas heart disease pathogenesis: one mechanism or many?

Authors:  Kevin M Bonney; David M Engman
Journal:  Curr Mol Med       Date:  2008-09       Impact factor: 2.222

4.  A cardiac myosin-specific autoimmune response is induced by immunization with Trypanosoma cruzi proteins.

Authors:  Juan S Leon; Melvin D Daniels; Krista M Toriello; Kegiang Wang; David M Engman
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

5.  Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.

Authors:  Anita R Schnapp; Chris S Eickhoff; Donata Sizemore; Roy Curtiss; Daniel F Hoft
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

6.  Heat-killed Trypanosoma cruzi induces acute cardiac damage and polyantigenic autoimmunity.

Authors:  Kevin M Bonney; Joann M Taylor; Melvin D Daniels; Conrad L Epting; David M Engman
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

7.  3-Hydroxy kynurenine treatment controls T. cruzi replication and the inflammatory pathology preventing the clinical symptoms of chronic Chagas disease.

Authors:  Carolina P Knubel; Fernando F Martínez; Eva V Acosta Rodríguez; Andrés Altamirano; Héctor W Rivarola; Cintia Diaz Luján; Ricardo E Fretes; Laura Cervi; Claudia C Motrán
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

8.  A refined genome phage display methodology delineates the human antibody response in patients with Chagas disease.

Authors:  André Azevedo Reis Teixeira; Luis Rodriguez Carnero; Andréia Kuramoto; Fenny Hui Fen Tang; Carlos Hernique Gomes; Natalia Bueno Pereira; Léa Campos de Oliveira; Regina Garrini; Jhonatas Sirino Monteiro; João Carlos Setubal; Ester Cerdeira Sabino; Renata Pasqualini; Walter Colli; Wadih Arap; Maria Júlia Manso Alves; Edécio Cunha-Neto; Ricardo José Giordano
Journal:  iScience       Date:  2021-05-15

9.  Cell death and serum markers of collagen metabolism during cardiac remodeling in Cavia porcellus experimentally infected with Trypanosoma cruzi.

Authors:  Yagahira E Castro-Sesquen; Robert H Gilman; Henry Paico; Verónica Yauri; Noelia Angulo; Fredy Ccopa; Caryn Bern
Journal:  PLoS Negl Trop Dis       Date:  2013-02-07

10.  Trypanosoma cruzi in persons without serologic evidence of disease, Argentina.

Authors:  Oscar A Salomone; Ana L Basquiera; Adela Sembaj; Ana M Aguerri; María E Reyes; Mirtha Omelianuk; Ruth A Fernández; Julio Enders; Atilio Palma; José Moreno Barral; Roberto J Madoery
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.